Hypolipidemic effect of the Chinese polyherbal Huanglian Jiedu decoction in type 2 diabetic rats and its possible mechanism

Phytomedicine

Volumn 21, Issue 5, 2014, Pages 615-623

  Zhang, Xiao Jie ^a   Deng, Yuan Xiong ^a   Shi, Qun Zhi ^a   He, Meng Yun ^a   Chen, Bo ^a   Qiu, Xi Min ^a  

^a HUNAN NORMAL UNIVERSITY   (China)

Author keywords

Huanglian Jiedu decoction (HLJDD); Low high density lipoprotein cholesterol; Pancreatic lipase; Total cholesterol; Triglyceride; Type 2 diabetes

Indexed keywords

ANTILIPEMIC AGENT; BAICALIN; BERBERINE; CHOLESTEROL; GENIPOSIDE; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HUANGLIAN JIEDU DECOCTION EXTRACT; LOW DENSITY LIPOPROTEIN CHOLESTEROL; OLIVE OIL; PLANT EXTRACT; STREPTOZOCIN; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; GLUCOSE BLOOD LEVEL; HERBACEOUS AGENT; LIPID; ORENGEDOKU TO; VEGETABLE OIL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CHINESE MEDICINE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; DRUG EFFECT; DRUG MEGADOSE; ENZYME ACTIVITY; ENZYME INHIBITION; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYPERLIPIDEMIA; HYPOLIPEMIA; IN VITRO STUDY; INTESTINE MUCOSA; LIPID DIET; LOADING TEST; LOW DRUG DOSE; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PHYTOCHEMISTRY; POSTPRANDIAL STATE; PRIORITY JOURNAL; RAT; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; TISSUE HOMOGENATE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL; ANIMAL; BLOOD; CHEMISTRY; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIAGNOSTIC USE; DRUG EFFECTS; EATING; ENZYMOLOGY; HYPERLIPIDEMIAS; LIPID METABOLISM; METABOLISM; PANCREAS; RANDOMIZATION; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BLOOD GLUCOSE; BODY WEIGHT; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DIABETES MELLITUS, TYPE 2; DRUGS, CHINESE HERBAL; EATING; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPASE; LIPID METABOLISM; LIPIDS; MALE; PANCREAS; PLANT OILS; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY;

EID: 84898057374     PISSN: 09447113     EISSN: 1618095X     Source Type: Journal    
DOI: 10.1016/j.phymed.2013.11.004     Document Type: Article

References (45)

1. G. Chen, F.E. Lu, and L.J. Xu Effects of Huanglian Jiedu Decoction on glucose transporter 4 in target tissues of type 2 diabetic rats Zhong Xi Yi Jie He Xue Bao 5 2007 412 415
2. Chinese Pharmacopoeia Commission The Pharmacopoeia of the People's Republic of China vol. 1 2010 Chemical Industry Press Beijing
3. Y.X. Deng, L. Liu, S. Yu, L. Xie, and X.D. Liu Simultaneous determination of geniposide and 4 flavonoids in the traditional Chinese medicinal preparation Huanglian Jiedu decoction by HPLC with programmed wavelength UV detection Chin. J. Pharmaceut. Anal. 28 2008 182 186
4. H. Dong, N. Wang, L. Zhao, and F. Lu Berberine in the treatment of type 2 diabetes mellitus: a systemic review and meta-analysis Evid. Based Complement. Alternat. Med. 2012 2012 591654
5. S.H. Eom, M.S. Lee, E.W. Lee, Y.M. Kim, and T.H. Kim Pancreatic lipase inhibitory activity of phlorotannins isolated from Eisenia bicyclis Phytother. Res. 27 2013 148 151
6. X.C. Fu, Z. Xu, Y. He, and H.Y. Chi Protective function of Huanglian Jiedu Tang on Rats after focal cerebral ischemic reperfusion and its influence on caspase-3 expression Mod. J. Integr. Tradit. Chin. West. Med. 18 2009 1598 1599
7. M. Fukutake, N. Miura, M. Yamamoto, K. Fukuda, O. Iijima, H. Ishikawa, M. Kubo, M. Okada, Y. Komatsu, H. Sasaki, K. Wakabayashi, A. Ishige, and S. Amagaya Suppressive effect of the herbal medicine Oren-gedoku-to on cyclooxygenase-2 activity and azoxymethane-induced aberrant crypt foci development in rats Cancer Lett. 157 2000 9 14
8. T. Hayashi, Y. Ohta, S. Inagaki, and N. Harada Inhibitory action of Oren-gedoku-to extract on enzymatic lipid peroxidation in rat liver microsomes Biol. Pharm. Bull. 24 2001 1165 1170
9. P.A. Hollander, S.C. Elbein, I.B. Hirsch, D. Kelley, J. McGill, T. Taylor, S.R. Weiss, S.E. Crockett, R.A. Kaplan, J. Comstock, C.P. Lucas, P.A. Lodewick, W. Canovatchel, J. Chung, and J. Hauptman Role of orlistat in the treatment of obese patients with type 2 diabetes: a 1-year randomized double-blind study Diabetes Care 21 1998 1288 1294
10. J.Y. Hwang, S.K. Lee, J.R. Jo, M.E. Kim, H.A. So, C.W. Cho, Y.W. Seo, and J.I. Kim Hypolipidemic effect of Salicornia herbacea in animal model of type 2 diabetes mellitus Nutr. Res. Pract. 1 2007 371 375
11. Y.S. Hwang, C.Y. Shin, Y. Huh, and J.H. Ryu Hwangryun-Hae-Dok-tang (Huanglian-Jie-Du-Tang) extract and its constituents reduce ischemia-reperfusion brain injury and neutrophil infiltration in rats Life Sci. 71 2002 2105 2117
12. N. Ikarashi, M. Tajima, K. Suzuki, T. Toda, K. Ito, W. Ochiai, and K. Sugiyama Inhibition of preadipocyte differentiation and lipid accumulation by Orengedokuto treatment of 3T3-L1 cultures Phytother. Res. 26 2012 91 100
13. J. Jin, Y. Zhang, W.X. Hu, Z.Y. Zhang, N.N. Xu, and Q.L. Zhou Effects of Huanglian Jiedu Decoction on blood lipid metabolism and its related gene expressions in rats with hyperlipidemia Zhong Xi Yi Jie He Xue Bao 8 2010 275 279
14. Y.S. Kim, E.A. Jung, J.E. Shin, J.C. Chang, H.K. Yang, N.J. Kim, K.H. Cho, H.S. Bae, S.K. Moon, and D.H. Kim Daio-Orengedokuto inhibits HMG-CoA reductase and pancreatic lipase Biol. Pharm. Bull. 25 2002 1442 1445
15. I.A. Lee, J.H. Lee, N.I. Baek, and D.H. Kim Antihyperlipidemic effect of crocin isolated from the fructus of Gardenia jasminoides and its metabolite Crocetin Biol. Pharm. Bull. 28 2005 2106 2110
16. Q. Li, L. Wang, R.H. Dai, and K.S. Bi Determination of berberine hydrochloride in coptis decoction by HPLC Northwest Pharm. J. 19 2004 51 52
17. Y. Lin, and Z. Sun Current views on type 2 diabetes J. Endocrinol. 204 2010 1 11
18. I. Lindner, U. Helwig, D. Rubin, Y. Li, E. Fisher, H. Boeing, M. Möhlig, J. Spranger, A. Pfeiffer, J. Hampe, S. Schreiber, F. Döring, and J. Schrezenmeir Putative association between a new polymorphism in exon 3 (Arg109Cys) of the pancreatic colipase gene and type 2 diabetes mellitus in two independent Caucasian study populations Mol. Nutr. Food Res. 49 2005 972 976
19. O.H. Lowry, N.J. Rosenbrough, A.L. Far, and R.J. Randall Protein measurement with Folin phenol reagent J. Biol. Chem. 193 1951 265 275
20. T. Lu, Y. Liang, J. Song, L. Xie, G.J. Wang, and X.D. Liu Simultaneous determination of berberine and palmatine in rat plasma by HPLC-ESI-MS after oral administration of traditional Chinese medicinal preparation Huang-Lian-Jie-Du decoction and the pharmacokinetic application of the method J. Pharmaceut. Biomed. Anal. 40 2006 1218 1224
21. J. Lu, J.S. Wang, and L.Y. Kong Anti-inflammatory effects of Huang-Lian-Jie-Du decoction, its two fractions and four typical compounds J. Ethnopharmacol. 134 2011 911 918
22. H. Makihara, T. Shimada, E. Machida, M. Oota, R. Nagamine, M. Tsubata, K. Kinoshita, K. Takahashi, and M. Aburada Preventive effect of Terminalia bellirica on obesity and metabolic disorders in spontaneously obese type 2 diabetic model mice J. Nat. Med. 66 2012 459 467
23. Y. Ohta, E. Sasaki, K. Nishida, M. Kongo, T. Hayashi, M. Nagata, and I. Ishiguro Inhibitory effect of Oren-gedoku-to (Huanglian-Jie-Du-Tang) extract on hepatic triglyceride accumulation with the progression of carbon tetrachloride-induced acute liver injury in rats J. Ethnopharmacol. 61 1998 75 80
24. M.J. Reed, K. Meszaros, L.J. Entes, M.D. Claypool, J.G. Pinkett, T.M. Gadbois, and G.M. Reaven A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat Metabolism 49 2000 1390 1394
25. E. Ros Intestinal absorption of triglyceride and cholesterol. Dietary and pharmacological inhibition to reduce cardiovascular risk Atherosclerosis 151 2000 357 379
26. N. Sekiya, M. Kainuma, H. Hikiami, T. Nakagawa, K. Kouta, N. Shibahara, Y. Shimada, and K. Terasawa Oren-gedoku-to and Keishi-bukuryo-gan-ryo inhibit the progression of atherosclerosis in diet-induced hypercholesterolemic rabbits Biol. Pharm. Bull. 28 2005 294 298
27. B. Sharma, C. Balomajumder, and P. Roy Hypoglycemic and hypolipidemic effects of flavonoid rich extract from Eugenia jambolana seeds on streptozotocin induced diabetic rats Food Chem. Toxicol. 46 2008 2376 2383
28. D. Shaw Toxicological risks of Chinese herbs Planta Med. 76 2010 2012 2018
29. L. Sheng, Z. Qian, S. Zheng, and L. Xi Mechanism of hypolipidemic effect of crocin in rats: crocin inhibits pancreatic lipase Eur. J. Pharmacol. 543 2006 116 122
30. K. Srinivasan, B. Viswanad, L. Asrat, C.L. Kaul, and P. Ramarao Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharmacol. Res. 52 2005 313 320
31. L.Q. Tang, W. Wei, L.M. Chen, and S. Liu Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats J. Ethnopharmacol. 108 2006 109 115
32. P. Trinder Determination of glucose using glucose oxidase with an alternative oxygen acceptor Ann. Clin. Biochem. 6 1969 24 27
33. J.T. Xie, A. Wang, S. Mehendale, J. Wu, H.H. Aung, L. Dey, S. Qiu, and C.S. Yuan Anti-diabetic effects of Gymnema yunnanense extract Pharmacol. Res. 47 2003 323 329
34. X. Xie, X. Meng, X. Zhou, X. Shu, and H. Kong Research on therapeutic effect and hemorrheology change of berberine in new diagnosed patients with type 2 diabetes combining nonalcoholic fatty liver disease Zhongguo Zhong Yao Za Zhi 36 2011 3032 3035
35. X.H. Xing, Z.M. Zhang, X.Z. Hu, R.Q. Wu, and C. Xu Antidiabetic effects of Artemisia sphaerocephala Krasch. gum, a novel food additive in China, on streptozotocin-induced type 2 diabetic rats J. Ethnopharmacol. 125 2009 410 416
36. W. Yang, J. Lu, J. Weng, W. Jia, L. Ji, J. Xiao, Z. Shan, J. Liu, H. Tian, Q. Ji, D. Zhu, J. Ge, L. Lin, L. Chen, X. Guo, Z. Zhao, Q. Li, Z. Zhou, G. Shan, J. He, and China National Diabetes and Metabolic Disorders Study Group Prevalence of diabetes among men and women in China N. Engl. J. Med. 362 2010 1090 1101
37. Y. Ye, C. Huang, L. Jiang, X. Shen, S. Zhu, Y. Rao, J. Wang, and Q. Zhang Huanglian-Jie-Du-Tang extract protects against chronic brain injury after focal cerebral ischemia via hypoxia-inducible-factor-1α-regulated vascular endothelial growth factor signaling in mice Biol. Pharm. Bull. 35 2012 355 361
38. J. Yin, H. Xing, and J. Ye Efficacy of berberine in patients with type 2 diabetes mellitus Metabolism 57 2008 712 717
39. R.Q. Yin, Y. Ding, M.D. Chen, M.L. Ju, and S.S. Huang Research on the inhibition mechanism of baicalin on pancreatic lipase J. Anhui Agric. Sci. 37 2009 11534 11536
40. S.C. Young, and D.Y. Hui Pancreatic lipase/colipase-mediated triacylglycerol hydrolysis is required for cholesterol transport from lipid emulsions to intestinal cells Biochem. J. 339 1999 615 620
41. Y.L. Yu, S.S. Lu, S. Yu, Y.C. Liu, P. Wang, L. Xie, G.J. Wang, and X.D. Liu Huang-Lian-Jie-Du-Decoction modulates glucagon-like peptide-1 secretion in diabetic rats J. Ethnopharmacol. 124 2009 444 449
42. H. Zeng, X. Liu, S. Dou, W. Xu, N. Li, X. Liu, W. Zhang, Z. Hu, and R. Liu Huang-Lian-Jie-Du-Tang exerts anti-inflammatory effects in rats through inhibition of nitric oxide production and eicosanoid biosynthesis via the lipoxygenase pathway J. Pharm. Pharmacol. 61 2009 1699 1707
43. H. Zeng, S. Dou, J. Zhao, S. Fan, X. Yuan, S. Zhu, L. Li, W. Zhang, and R. Liu The inhibitory activities of the components of Huang-Lian-Jie-Du-Tang (HLJDT) on eicosanoid generation via lipoxygenase pathway J. Ethnopharmacol. 135 2011 561 568
44. Q. Zhang, Y.L. Ye, Y.X. Yan, W.P. Zhang, L.S. Chu, E.Q. Wei, and Y.P. Yu Protective effects of Huanglian-Jiedu-Tang on chronic brain injury after focal cerebral ischemia in mice Zhejiang Da Xue Xue Bao Yi Xue Ban 38 2009 75 80
45. Q. Zhang, X. Xiao, K. Feng, T. Wang, W. Li, T. Yuan, X. Sun, Q. Sun, H. Xiang, and H. Wang Berberine moderates glucose and lipid metabolism through multipathway mechanism Evid. Based Complement. Altern. Med. pii 2011 924851 10.1155/2011/924851